Dr. Rangaswamy Govindarajan has been named chief of the division of hematology and oncology at UAMS Winthrop P. Rockefeller Cancer Institute.
Govindarajan, who is also a professor in the division, will lead a team of physicians treating patients with benign and malignant hematological disorders, multiple myeloma and solid tumors, UAMS said in a news release. The division includes the state’s only stem cell, bone marrow transplant and cellular therapy program.
Govindarajan will also help the faculty develop clinical trials, including translational research.
“Dr. Govindarajan is the ideal person for this key leadership role at a dynamic time as we introduce cutting edge new treatments, expand our care teams, create a cancer network with Baptist Health and pursue NCI designation,” Michael Birrer, director of the institute and UAMS vice chancellor, said in a news release.
Govindarjan joined UAMS in 1998 after completing his medical training at UAMS. He is board certified in internal medicine and hematology and oncology, and a diplomate of the American Board of Internal Medicine and the National Board of Internal Medicine.
Govindarajan received his medical degree from Mysore Medical College, University of Mysore in Mysore, India. He is also a member of the Royal College of physicians, United Kingdom.
